Neotrace-4
FDA Approves Dotarem, a New MRI Agent »
"The U.S. Food and Drug Administration today approved Dotarem (gadoterate meglumine) for use in magnetic resonance imaging (MRI) of the brain, spine and associated tissues of patients ages 2 years and older.
Dotarem is a gadolinium-based"...
Neotrace-4
SIDE EFFECTS
The amounts of zinc, copper, chromium and manganese in Neotrace®-4 are very small and toxicity symptoms due to these trace elements at suggested dosage levels are considered unlikely to occur.
Drug Abuse and Dependence
None known.
Read the Neotrace-4 (metal-4 combination (for neonates)) Side Effects Center for a complete guide to possible side effects »
DRUG INTERACTIONS
No information provided.
Last reviewed on RxList: 12/8/2004
This monograph has been modified to include the generic and brand name in many instances.
Additional Neotrace-4 Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Women's Health
Find out what women really need.
Updated & New
